| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/14/2015 | CN103976964B 依托红霉素片及其制备方法 Relying on erythromycin tablets and preparation method |
| 01/14/2015 | CN103405392B 一种夫西地酸钠冻干粉针剂专用注射剂及其制备方法 One kind of freeze-dried powder sodium fusidate special injection and its preparation method |
| 01/14/2015 | CN103405389B 兽用孟布酮粉及其制备方法 Veterinary Mengbu ketone powder and its preparation method |
| 01/14/2015 | CN103239397B 一种奥拉西坦注射液组合物及其制备方法 An injection composition and preparation method oxiracetam |
| 01/14/2015 | CN103211762B 诊疗一体化新型杂化胶束及其制备方法 Clinic integration of new hybrid micelles and its preparation method |
| 01/14/2015 | CN103183724B 多西紫杉醇共缀物的制备方法 A total of docetaxel conjugates preparation thereof |
| 01/14/2015 | CN103172819B 侧链带有氨基的可生物降解聚氨酯及其制备方法和用途 Bio-degradable polyurethane amino side chains with their preparation and use |
| 01/14/2015 | CN103145968B 叶酸偶联聚乙二醇单硬脂酸酯及其制备方法与应用 Folate-conjugated polyethylene glycol monostearate and its preparation method and application |
| 01/14/2015 | CN103142531B 一种阿司匹林缓释片及其制备方法 One kind of sustained-release tablets of aspirin and its preparation method |
| 01/14/2015 | CN103083275B 一种非诺贝酸及其生理学上可接受盐的肠溶片及其制备方法 On a non-Nobel acid and physiologically acceptable salts of enteric-coated tablets and its preparation method |
| 01/14/2015 | CN103027895B 一种无糖型西尼地平干混悬剂及其制备方法 One kind of sugar-free dry suspension Cilnidipine its preparation method |
| 01/14/2015 | CN102973513B 智能纳米药物传递系统和制备方法及应用 Smart nano drug delivery systems and preparation method and application |
| 01/14/2015 | CN102970982B 肠溶片剂 Enteric-coated tablets |
| 01/14/2015 | CN102949727B 靶向性抗肿瘤药物和基因共载载体材料及制备和应用 Anticancer drugs and gene targeting vector containing a total of material and preparation and application |
| 01/14/2015 | CN102725001B 抗增殖化合物、其缀合物、其方法及其用途 Antiproliferative compounds, their conjugates, and their method of use |
| 01/14/2015 | CN102657611B 丙酮酸钠鼻喷剂及其制备方法 Sodium pyruvate nasal spray and its preparation method |
| 01/14/2015 | CN102573920B 非凝血蛋白的糖基多唾液酸化 Non-clotting protein sialylated sugar Quito |
| 01/14/2015 | CN102283817B 可持续释放药物的组合物及其用途 Sustainable release pharmaceutical compositions and uses thereof |
| 01/14/2015 | CN102099408B 聚合物微凝胶珠及其制备方法 Polymer microgel beads and its preparation method |
| 01/14/2015 | CN102026629B 透皮吸收制剂 Transdermal preparations |
| 01/14/2015 | CN102008456B 含有美托洛尔琥珀酸盐的新型骨架缓释片 Novel Sustained Release Tablets containing metoprolol succinate |
| 01/14/2015 | CN101979404B H5亚型禽流感病毒保守中和表位模拟肽及其用途 H5 subtype avian influenza virus conserved neutralization epitope mimetics and their use |
| 01/14/2015 | CN101646443B 速效型核酸转运用载体组合物 Fast-acting nucleic acid delivery carrier composition |
| 01/14/2015 | CN101212986B 稳定的乳化组合物 Stable emulsified composition |
| 01/13/2015 | US8933245 Preservation of ergothioneine |
| 01/13/2015 | US8933218 Conjugation process for PNAG and a carrier protein |
| 01/13/2015 | US8933207 Drug-ligand conjugates, synthesis thereof, and intermediates thereto |
| 01/13/2015 | US8933205 Process for preparing purified drug conjugates |
| 01/13/2015 | US8933203 Vault and vault-like carrier molecules |
| 01/13/2015 | US8933199 Fibronectin based scaffold domain proteins that bind to myostatin |
| 01/13/2015 | US8933127 Enhanced bimatoprost ophthalmic solution |
| 01/13/2015 | US8933119 Method for treating phytophotodermatitis |
| 01/13/2015 | US8933115 Stabilized statin formulations |
| 01/13/2015 | US8933112 Topical liquid to ameliorate pain and promote healing of burn-injured skin |
| 01/13/2015 | US8933059 Natural combination hormone replacement formulations and therapies |
| 01/13/2015 | US8933058 Targetted drug delivery to the bone |
| 01/13/2015 | US8933057 Crystallization method and bioavailability |
| 01/13/2015 | US8933047 Poly(acrylate) polymers for in vivo nucleic acid delivery |
| 01/13/2015 | US8933029 Antimicrobial and anti-inflammatory peptides |
| 01/13/2015 | US8933027 Method of treating a disease or condition characterised by aberrant epithelial cell proliferation |
| 01/13/2015 | US8933023 Rapid acting injectable insulin compositions |
| 01/13/2015 | US8933013 Co-administration of an agent linked to an internalization peptide with an anti-inflammatory |
| 01/13/2015 | US8932828 Method for preparing recombinant granulocyte colony stimulating factor cysteine muteins |
| 01/13/2015 | US8932655 Antiseptic teat dip microemulsion |
| 01/13/2015 | US8932638 Polyamine derivatives |
| 01/13/2015 | US8932615 Implantable devices formed on non-fouling methacrylate or acrylate polymers |
| 01/13/2015 | US8932594 Adjuvants and methods of use |
| 01/13/2015 | US8932591 Formulation of human antibodies for treating TNF-α associated disorders |
| 01/13/2015 | US8932574 Stable liquid interferon beta formulations |
| 01/13/2015 | US8932572 Poly(vinyl ester) polymers for in vivo nucleic acid delivery |
| 01/13/2015 | US8932566 Composition comprising a polyol and a oil-soluble polar modified polymer |
| 01/13/2015 | US8932560 Advanced functional biocompatible polymeric matrix used as a hemostatic agent and system for damaged tissues and cells |
| 01/13/2015 | US8931490 Systems and methods for nanomagnetic actuation of molecular cell signaling |
| 01/13/2015 | CA2676981C Powders for reconstitution |
| 01/13/2015 | CA2623429C Interleukin-13 antibody composition |
| 01/13/2015 | CA2622342C Processing of chitosan and chitosan derivatives |
| 01/13/2015 | CA2607020C Alpha amino acid ester-drug conjugates hydrolysable by carboxylesterases |
| 01/13/2015 | CA2540666C Glucocerebroside treatment of disease |
| 01/08/2015 | WO2015003149A2 Soluble cd33 for treating myelodysplastic syndromes (mds) |
| 01/08/2015 | WO2015002569A1 Method for immobilizing therapeutic drugs on the surface of detonation nanodiamonds |
| 01/08/2015 | WO2015002091A1 Water-soluble hyaluronic acid gel and method for producing same |
| 01/08/2015 | WO2015002078A1 Novel boronic acid compound preparation |
| 01/08/2015 | WO2015001995A1 Rocuronium preparation with improved vascular pain, method for producing same, and method for suppressing and relieving vascular pain using same |
| 01/08/2015 | WO2015001478A1 Liquid pharmaceutical composition for oral administration comprising fexofenadine |
| 01/08/2015 | WO2015001361A1 Immunotherapy |
| 01/08/2015 | WO2015001175A1 Edible composition suitable for lowering serum cholesterol |
| 01/08/2015 | WO2015001133A1 Pharmaceutical composition comprising amorphous ivabradine |
| 01/08/2015 | WO2015000585A1 Muteins of cytokines of the gamma-chain receptor family conjugated to a non-protein group |
| 01/08/2015 | WO2015000062A1 Egfr antibody conjugates |
| 01/08/2015 | WO2015000058A1 Biophotonic compositions comprising a chromophore and a gelling agent for treating wounds |
| 01/08/2015 | US20150011736 Binding molecule conjugates |
| 01/08/2015 | US20150011732 Polymer conjugates of interferon beta-1a and uses |
| 01/08/2015 | US20150011660 High-Purity Rubusoside And Process For Producing Of The Same |
| 01/08/2015 | US20150011659 Low protein percentage gelling compositions |
| 01/08/2015 | US20150011644 Methods and Compositions for Deterring Abuse |
| 01/08/2015 | US20150011641 High load dispersions |
| 01/08/2015 | US20150011638 Alprostadil and lidocaine treatment of premature ejaculation |
| 01/08/2015 | US20150011635 Diclofenac topical formulation |
| 01/08/2015 | US20150011634 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid |
| 01/08/2015 | US20150011633 Pharmaceutical formulations containing lipoic acid derivatives |
| 01/08/2015 | US20150011615 Carbohydrate Conjugates as Delivery Agents for Oligonucleotides |
| 01/08/2015 | US20150011608 iRNA Agents Targeting VEGF |
| 01/08/2015 | US20150011602 Stabilized pharmaceutical dosage forms comprising atrasentan |
| 01/08/2015 | US20150011596 Topical localized isoxazoline formulation comprising glycofurol |
| 01/08/2015 | US20150011588 Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid |
| 01/08/2015 | US20150011587 Alprostadil for treatment of premature ejaculation |
| 01/08/2015 | US20150011585 Alprostadil and dyclonine for treatment of premature ejaculation |
| 01/08/2015 | US20150011577 Oxymorphone controlled release formulations |
| 01/08/2015 | US20150011570 Transdermal delivery of beneficial substances effected by a hostile biophysical environment |
| 01/08/2015 | US20150011525 Solid dispersion of poorly soluble compounds comprising crospovidone and at least one water-soluble polymer |
| 01/08/2015 | US20150011521 Methods for in vivo drug delivery with porous nanostructures |
| 01/08/2015 | US20150011520 Pharmaceutical compositions to reduce complications of ocular steroid |
| 01/08/2015 | US20150011518 Non-aqueous liquid composition |
| 01/08/2015 | US20150011515 Hormone Containing Emulsion |
| 01/08/2015 | US20150011512 Treatment or prophylaxis of proliferative conditions |
| 01/08/2015 | US20150011507 Compositions comprising lecithin oils and nsaids for protecting the gastrointestinal tract and providing enhanced therapeutic activity |
| 01/08/2015 | US20150011502 Methods and compositions to treat myocardial conditions |
| 01/08/2015 | US20150011483 Inhibition of HIV-1 Infection by Potent Metallocene Conjugated Peptide Through Conformational Entrapment of Envelope GP120 |
| 01/08/2015 | US20150011473 Stabilized pth formulation |
| 01/08/2015 | US20150011468 Uses of casein compositions |